StemWave shockwave therapy demonstrates success rates between 80-90% for chronic pain sufferers using acoustic wave technology The treatment effectively addresses joint pain, tendonitis, back pain, ...
Automated cell manufacturing company Mytos has signed an agreement with Aspen Neuroscience, a clinical-stage private company focused on autologous regenerative medicine, to automate the manufacture of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results